copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agentes antineoplásicos - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomioma - hormonas e análises pituitárias e hipotalâmicas - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunossupressores - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - agentes antineoplásicos - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
vydura
pfizer europe ma eeig - rimegepant - transtornos da enxaqueca - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
glucovance 2.5 mg + 500 mg comprimido revestido por película
merck, s.a. - glibenclamida + metformina - comprimido revestido por película - 2.5 mg + 500 mg - metformina, cloridrato 500 mg ; glibenclamida 2.5 mg - metformin and sulfonylureas - n/a - duração do tratamento: longa duração
ciclosporina teva 50 mg cápsula mole
teva pharma - produtos farmacêuticos, lda. - ciclosporina - cápsula mole - 50 mg - ciclosporina 50 mg - ciclosporin - genérico - duração do tratamento: longa duração
ciclosporina teva 50 mg cápsula mole
teva pharma - produtos farmacêuticos, lda. - ciclosporina - cápsula mole - 50 mg - ciclosporina 50 mg - ciclosporin - genérico - duração do tratamento: longa duração
darunavir zentiva 600 mg comprimido revestido por película
zentiva portugal, lda. - darunavir - comprimido revestido por película - 600 mg - darunavir 600 mg - darunavir - genérico - duração do tratamento: longa duração
ciclosporina generis 100 mg cápsula mole
generis farmacêutica, s.a. - ciclosporina - cápsula mole - 100 mg - ciclosporina 100 mg - ciclosporin - genérico - duração do tratamento: longa duração